Curetis to Present at Key Investor and Scientific

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
186
Curetis to Present at Key Investor and Scientific Conferences in the First Quarter 2017

Curetis to Present at Key Investor and Scientific Conferences in the First Quarter 2017

Amsterdam, the Netherlands, and Holzgerlingen, Germany, January 4, 2017 -- Curetis N.V. (the " Company " and, together with Curetis GmbH, " Curetis "), a developer of next-level molecular diagnostic solutions, today announced its participation in several industry conferences in the first quarter of 2017. The respective presentations will be made available on the company's website.

January:

J.P. Morgan 35th Annual Healthcare Conference 2017 , January 9-13, 2017 - San Francisco, CA, USA: one-on-one meetings.

Society of Critical Care Medicine's (SCCM) 46th Critical Care Congress , January 21-25, 2017 - Honolulu, Hawaii, USA: exhibition booth: 924.

Invest Securities BioMed Event, January 26, 2017 - Paris, France: company presentation and one-on-one meetings.

DeGroof Petercam Life Sciences Investor Day , January 31, 2017 - Brussels, Belgium: one-on-one meetings.

February:

3rd Annual Medtech & Money Healthcare Conference , February 7-8, 2017 - London, United Kingdom: company presentation and one-on-one meetings.

BIO CEO & Investor Conference , February 13-14, 2017 - New York, NY, USA: company presentation and one-on-one meetings.

RBC Healthcare Conference 2017 , February 22-23, 2017 - New York, NY, USA: company presentation and one-on-one meetings.

March:

Microbiology and Infection 2017; 5th Joint Conference of the DGHM & VAAM VAAM Annual Meeting 2017; 69th Annual Meeting of the DGHM , March 5-8, 2017 - Wuerzburg, Germany.

Sachs 10th European Life Science CEO Forum & Exhibition , March 6-7, 2017 - Basel, Switzerland: company presentation and one-on-one meetings.

BioCapital Europe 2017 , March 15, 2017 - Amsterdam, The Netherlands: company presentation and one-on-one meetings.

### About Curetis Founded in 2007, Curetis is a molecular diagnostics company which focuses on the development and commercialization of reliable, fast and cost-effective products for diagnosing severe infectious diseases. The diagnostic solutions of Curetis enable rapid multi-parameter pathogen and antibiotic resistance marker detection in only a few hours, a process that today can take up to days or even weeks with other techniques.

To date, Curetis has raised EUR 44.3 million in an IPO on Euronext Amsterdam and Euronext Brussels and private equity funds of over EUR 63.5 million. Furthermore, Curetis has entered into a debt financing facility with EIB for up to EUR 25 million. The company is based in Holzgerlingen near Stuttgart, Germany. Curetis has signed collaboration agreements with Heraeus Medical and Cempra Inc. as well as several international distribution agreements covering many countries across Europe, the Middle East and Asia. For further information, please visit www.curetis.com .

Legal Disclaimer This document constitutes neither an offer to buy nor to subscribe securities and neither this document nor any part of it should form the basis of any investment decision in Curetis.

The information contained in this press release has been carefully prepared. However, Curetis bears and assumes no liability of whatever kind for the correctness and completeness of the information provided herein. Curetis does not assume an obligation of whatever kind to update or correct information contained in this press release whether as a result of new information, future events or for other reasons.

This press release includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "may", "will", or "should", and include statements Curetis makes concerning the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are cautioned that any such forward-looking statements are not guarantees of future performance. Curetis' actual results may differ materially from those predicted by the forward-looking statements. Curetis undertakes no obligation to publicly update or revise forward-looking statements, except as may be required by law.

Contact details

Curetis Max-Eyth-Str. 42 71088 Holzgerlingen, Germany Tel. +49 7031 49195-10 pr@curetis.com or ir@curetis.com www.curetis.com - www.unyvero.com

International Media & Investor Inquiries akampion Dr. Ludger Wess / Ines-Regina Buth Managing Partners info(@)akampion.com Tel. +49 40 88 16 59 64 Tel. +49 30 23 63 27 68

U.S. Media & Investor Inquiries The Ruth Group Lee Roth lroth@theruthgroup.com Tel. +1 646 536 7012

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...4bc32dcd8d

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/Attachm...f82be735bb

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pushing for National Liver Cancer Awareness in 2026

Updated Category News Views 18

The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...

Continue Reading
ROKFORM’s Signal Card: A Wallet Tracker for All

Updated Category News Views 11

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Continue Reading
Karoo Health Leaps Forward with New CCO Breton

Updated Category News Views 16

Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...

Continue Reading
Charter Next Generation Unveils Gen 2 MDO-PE Films

Updated Category News Views 14

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Continue Reading
TA Services Strengthens U.S.-Mexico Freight Operations

Updated Category News Views 23

TA Services Moves Boldly Across Borders If ever there was a time to play the logistics chessboard like a champ, it's now, and TA Services just slammed the board with a solid move. They've grabbed Carmen Pacheco Transportation and Interload Forwarding, two family-run operations with some real muscle in North American logistics. This isn't a small-time maneuver; they've...

Continue Reading
Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

Updated Category News Views 21

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Continue Reading
IWP and VYRE Unveil 'The Plug' for VBNGtv Content

Updated Category News Views 20

Bringing Capital and Content Under One Roof There's something in the air as Itibari-Waynne & Partners (IWP) team up with the VYRE Network to crank out a fresh slate of content for VYRE Business News Global (VBNGtv). This partnership ain't just another splash in the buzzy world of digital media; it's like merging Wall Street with Hollywood. IWP, prepping to go full...

Continue Reading
JiMMYBAR! Expands Creatine Market with Target Launch

Updated Category News Views 25

JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...

Continue Reading
Epic Political Thriller Explores Humanity's Future

Updated Category News Views 12

Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...

Continue Reading
Skandia's Soundproofing Kit Expands to Brazil's Skies

Updated Category News Views 14

Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...

Continue Reading

Top 5 Most Recently Viewed Articles

AGNC Investment Corp. Publishes Incremental Dividend Announcement

Updated Category News Views 141

AGNC Investment Corp. Announces Cash Dividend for Shareholders AGNC Investment Corp. has recently declared its cash dividend for shareholders, a testament to its ongoing commitment to delivering value and returns. This monthly dividend is set at $0.12 per share of common stock and will greatly benefit investors looking for steady income. Details of the Dividend...

Continue Reading
Gentoo Media's Q4 2025 Update and 2026 Projections Explained

Updated Category News Views 137

Gentoo Media's Trading Update and Future Guidance Gentoo Media Inc. announces today an overview of its trading performance for the fourth quarter of 2025, along with preliminary guidance for the entire financial year of 2026. Additionally, they are set to initiate a refinancing process for their bonds and credit facility. Quarter 4 and Full-Year Performance Highlights In...

Continue Reading
Anheuser-Busch's $4.2 Million Investment in Brewery Drives Growth

Updated Category News Views 481

Anheuser-Busch's Significant Investment in Local Manufacturing Anheuser-Busch, a prominent name in the brewing industry known for its iconic brands like Budweiser and Michelob ULTRA, has announced a substantial $4.2 million investment in one of its breweries. This strategic move is not just about enhancing their operations; it's about fostering local economic growth and...

Continue Reading
Japan's Economic Outlook Amid Global Uncertainties

Updated Category News Views 157

Japan's Economic Landscape in a Changing World In recent times, Japan's government has been deliberately cautious regarding its economic forecast. This hesitance largely stems from the scrutiny of global events, particularly the actions and policies set forth by the U.S. administration. These decisions could significantly sway not only the domestic landscape but the...

Continue Reading
Understanding Sogeclair's Voting Rights for Stakeholders

Updated Category News Views 122

Insights into Sogeclair's Voting Rights Structure SOGECLAIR Business corporation with a capital of 3,204,901 Euros Head Office: 7 avenue Albert Durand – 31700 BLAGNAC Tel.: +33 (0)5.61.71.71.71 As a key player in its industry, Sogeclair provides important information regarding the total number of voting rights associated with its shares and capital structure. This...

Continue Reading